|Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline|
K Talbot, HY Wang, H Kazi, LY Han, KP Bakshi, A Stucky, RL Fuino, ...
The Journal of clinical investigation 122 (4), 1316-1338, 2012
|An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers|
TR Bomfim, L Forny-Germano, LB Sathler, J Brito-Moreira, JC Houzel, ...
The Journal of clinical investigation 122 (4), 1339-1353, 2012
|Altered neuregulin 1–erbB4 signaling contributes to NMDA> receptor hypofunction in schizophrenia|
CG Hahn, HY Wang, DS Cho, K Talbot, RE Gur, WH Berrettini, K Bakshi, ...
Nature medicine 12 (7), 824-828, 2006
|Gene expression elucidates functional impact of polygenic risk for schizophrenia|
M Fromer, P Roussos, SK Sieberts, JS Johnson, DH Kavanagh, ...
Nature neuroscience 19 (11), 1442-1453, 2016
|Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia|
K Talbot, WL Eidem, CL Tinsley, MA Benson, EW Thompson, RJ Smith, ...
The Journal of clinical investigation 113 (9), 1353-1363, 2004
|Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain|
E Hellstr÷m-Lindahl, M Mousavi, X Zhang, R Ravid, A Nordberg
Molecular brain research 66 (1-2), 94-103, 1999
|Acetylcholinesterase neurons in dopamine-containing regions of the brain|
LL Butcher, K Talbot, L Bilezikjian
Journal of neural transmission 37 (2), 127-153, 1975
|Neurodevelopment, neuroplasticity, and new genes for schizophrenia|
SE Arnold, K Talbot, CG Hahn
Progress in brain research 147, 319-345, 2005
|Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer's disease|
N Louneva, JW Cohen, LY Han, K Talbot, RS Wilson, DA Bennett, ...
The American journal of pathology 173 (5), 1488-1495, 2008
|Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin|
K Talbot, DS Cho, WY Ong, MA Benson, LY Han, HA Kazi, J Kamins, ...
Human molecular genetics 15 (20), 3041-3054, 2006
|Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression|
J Tang, RP LeGros, N Louneva, L Yeh, JW Cohen, CG Hahn, DJ Blake, ...
Human molecular genetics 18 (20), 3851-3863, 2009
|Association of anxiety and depression with microtubule-associated protein 2–and synaptopodin-immunolabeled dendrite and spine densities in hippocampal CA3 of older humans|
A Soetanto, RS Wilson, K Talbot, A Un, JA Schneider, M Sobiesk, J Kelly, ...
Archives of general psychiatry 67 (5), 448-457, 2010
|Age-dependent synuclein pathology following traumatic brain injury in mice|
K Uryu, BI Giasson, L Longhi, D Martinez, I Murray, V Conte, M Nakamura, ...
Experimental neurology 184 (1), 214-224, 2003
|Neurobehavioral abnormalities in the dysbindin‐1 mutant, sandy, on a C57BL/6J genetic background|
MM Cox, AM Tucker, J Tang, K Talbot, DC Richer, L Yeh, SE Arnold
Genes, Brain and Behavior 8 (4), 390-397, 2009
|Cholinergic–Monoaminergic Interactions in the Brain|
|The nature, significance, and glucagon‐like peptide‐1 analog treatment of brain insulin resistance in Alzheimer's disease|
K Talbot, HY Wang
Alzheimer's & Dementia 10, S12-S25, 2014
|Dysbindin-1 mutant mice implicate reduced fast-phasic inhibition as a final common disease mechanism in schizophrenia|
GC Carlson, K Talbot, TB Halene, MJ Gandal, HA Kazi, L Schlosser, ...
Proceedings of the National Academy of Sciences 108 (43), E962-E970, 2011
|Measuring cell-type specific differential methylation in human brain tissue|
CM Monta˝o, RA Irizarry, WE Kaufmann, K Talbot, RE Gur, AP Feinberg, ...
Genome biology 14 (8), 1-9, 2013
|Synaptic dysbindin-1 reductions in schizophrenia occur in an isoform-specific manner indicating their subsynaptic location|
K Talbot, N Louneva, JW Cohen, H Kazi, DJ Blake, SE Arnold
PloS one 6 (3), e16886, 2011
|A frontal variant of Alzheimer’s disease exhibits decreased calcium-independent phospholipase A2 activity in the prefrontal cortex|
K Talbot, RA Young, C Jolly-Tornetta, VMY Lee, JQ Trojanowski, BA Wolf
Neurochemistry international 37 (1), 17-31, 2000